Share
Wharton Moneyball
7/22/2020: COVID-19, Sports, David Fajgenbaum
David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.
One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.
Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.
More episodes
View all episodes
The Signals That Matter After NFL Week 1
01:14:17|The first week of the NFL season creates more opinions than answers.Tej Seth, data scientist, breaks down how analysts can distinguish meaningful early-season signals from misleading results. He explains why offensive scheme changes can matter more than raw Week 1 statistics, why turnovers and late-down performance should be treated carefully, and how models should update after surprising games.The conversation examines the Baltimore Ravens' evolving offense, the Kansas City Chiefs' new running game, San Francisco's edge over the Rams, and the matchups worth watching as the NFL season takes shape.
Is this NFL season more wide open than it appears?
58:57|Is this NFL season more wide open than it appears?Brian Burke, Sports Data Scientist at ESPN, and Kevin Cole, Data Scientist at PFF, use football analytics to examine the season ahead. Burke explains how tracking data is changing the way teams measure pass protection and pressure, while Cole breaks down quarterback projections, team strength, and why the league's top contenders may be closer together than expected.
What Analytics Reveal About College Football's Top Teams
01:06:58|The road to the College Football Playoff is not as straightforward as a preseason ranking suggests.Bill Connelly, ESPN staff writer and creator of SP+, breaks down the analytics shaping the college football season. He examines why roster turnover creates a wider range of outcomes, how schedule strength affects playoff chances, the difference between the SEC and Big Ten, and the teams best positioned to contend. He also shares what his season simulations reveal about the title race and why a few unexpected teams could break through.
College Football's New Power Structure
01:06:13|What happens when college football players can make more money by staying in school than by entering the NFL?Steven Godfrey, college football journalist and co-host of Yahoo's College Football Enquirer, examines the financial incentives reshaping college football. He discusses NIL deals, transfer rules, eligibility loopholes, and why former NFL players attempting to return to college football could test the sport's limits.Godfrey also breaks down the Big Ten and SEC, coaching pressure at USC and Michigan, conference depth, playoff paths, and why Notre Dame and Ohio State stand out in the national championship picture.
How Data Changed MLB Pitching
01:08:24|Why are today's MLB pitchers harder to hit than ever?Adam Ottavino, former 15-year MLB reliever and current ESPN analyst, explains how pitch-tracking data, high-speed cameras, and personalized pitching labs reshaped his own career and changed player development across baseball. He breaks down how pitchers design new pitches, use bat-tracking data to attack hitters, and adapt their strategy from pitch to pitch.Ottavino also examines why pitching may have gained an edge over hitting, how teams use data to plan pitch selection, the limits of velocity, automated ball-strike challenges, and what a temporary velocity drop can mean for a pitcher such as Paul Skenes.
The NFL's Biggest 2026 Questions
01:09:15|Which NFL teams are the numbers backing before the 2026 season begins?Aaron Schatz, National NFL Analyst at ESPN and Chief Analytics Officer at FTN Fantasy, explains why the Houston Texans stand out in the AFC and why the Seattle Seahawks project as one of the league's strongest teams. He breaks down the Rams' Super Bowl outlook, the Bills' defense, the Eagles' path through the NFC East, and the teams that could surprise or regress.Schatz also explores how DVOA-based forecasts account for quarterback performance, coaching changes, injuries, schedules, and the balance of offense, defense, and special teams. Plus, why even the best projections leave plenty of room for the chaos of an NFL season.
Why Pitch Counts Are Failing Baseball
01:02:46|What if baseball’s most trusted pitching limit is more habit than science? Travis Sawchik, baseball analytics writer and author of Big Data Baseball and The MVP Machine, breaks down why pitch counts can miss the real stress on a pitcher’s arm, how workload units and acute-to-chronic ratios offer a better view of fatigue, and why teams may need to rethink how they build pitching capacity.The conversation also covers MLB trade deadline strategy, the Dodgers’ title odds, the Brewers’ risk calculus, when teams should chase variance instead of average gains, Baker Mayfield’s recent production compared with Patrick Mahomes, the Ravens’ coaching changes, Saquon Barkley’s workload, and college football playoff storylines.
Can the Sixers’ New Superteam Work?
01:02:47|Can the Philadelphia 76ers turn a roster featuring LeBron James, Joel Embiid, Tyrese Maxey, Jaylen Brown, and VJ Edgecombe into a championship team?Basketball analytics pioneer and ESPN data scientist Dean Oliver joins the Wharton Moneyball team to examine how Philadelphia might distribute possessions among so many high-usage players, whether LeBron can succeed as a point forward, and who should control the ball in critical late-game situations. The conversation also explores three-point shooting, defensive concerns, and why analytics can measure player performance more easily than it can predict chemistry and fit.Plus, the hosts discuss the enduring appeal of the Baseball Hall of Fame and the arrival of corporate jersey sponsorships in college football.
How Constraints Shape Creativity and Athletic Development
01:00:13|The right limits can lead to better ideas and better performance.David Epstein, bestselling author of The Sports Gene, Range, and Inside the Box: How Constraints Make Us Better, joins Wharton Moneyball to explore how constraints can strengthen creativity, focus, and decision-making.Epstein discusses the value of tight briefs and rapid prototypes, why first ideas are not always the best ideas, and why young athletes may benefit from playing multiple sports before specializing.